▷▷ Naturaligner Revenue and Competitors
Estimated Revenue & Valuation
- ▷▷ Naturaligner's estimated annual revenue is currently $2.3M per year.
- ▷▷ Naturaligner's estimated revenue per employee is $251,000
Employee Data
- ▷▷ Naturaligner has 9 Employees.
- ▷▷ Naturaligner grew their employee count by -50% last year.
▷▷ Naturaligner's People
Name | Title | Email/Phone |
---|
▷▷ Naturaligner Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is ▷▷ Naturaligner?
Bottmedical AG is a Swiss deep-tech spin-off from the University of Basel - A start-up founded by scientists and supported by international investors who share the same vision "Scientific knowledge - designed for patients and consumers". First, we envision disrupt the market of clear aligner therapies with a breakthrough bio-based material system for a body-friendly and comfortable teeth alignment (www.bottmedical.ch/naturaligner). As a pipeline, we work on launching an innovative solution for snoring and sleep apnea therapies in 2021. Our TOFI Trainer, a tongue-machine interface, is sensitive to the tongue's position & force. This enables the patient to drive a gamified training app with the tongue and thus, regain control over the tongue's strength during sleep (www.bottmedical.ch/tofi).
keywords:N/AN/A
Total Funding
9
Number of Employees
$2.3M
Revenue (est)
-50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.3M | 9 | -50% | N/A |
#2 | $0.9M | 9 | N/A | N/A |
#3 | $1.1M | 9 | 13% | N/A |
#4 | $0.8M | 10 | -9% | N/A |
#5 | $1.5M | 10 | -17% | N/A |